CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $308,000 | -49.5% | 20,500 | -17.7% | 0.00% | -66.7% |
| Q2 2020 | $610,000 | +52.5% | 24,900 | -11.7% | 0.00% | +50.0% |
| Q1 2020 | $400,000 | -10.5% | 28,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $447,000 | -5.7% | 28,200 | -50.0% | 0.00% | +100.0% |
| Q3 2019 | $474,000 | +253.7% | 56,400 | +276.0% | 0.00% | 0.0% |
| Q2 2019 | $134,000 | +605.3% | 15,000 | +500.0% | 0.00% | – |
| Q1 2019 | $19,000 | +72.7% | 2,500 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2018 | $22,000 | -24.1% | 2,500 | 0.0% | 0.00% | – |
| Q2 2018 | $29,000 | -17.1% | 2,500 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LP | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |